{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:50:10Z","timestamp":1759564210242},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.rbmo.2009.09.021","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T20:40:19Z","timestamp":1258663219000},"page":"789-795","source":"Crossref","is-referenced-by-count":17,"title":["Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase"],"prefix":"10.1016","volume":"19","author":[{"given":"TG","family":"Lainas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"IA","family":"Sfontouris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"IZ","family":"Zorzovilis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GK","family":"Petsas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GT","family":"Lainas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Alexopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EM","family":"Kolibianakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2009.09.021_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/humupd\/dmg018","article-title":"Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures","volume":"9","author":"Aboulghar","year":"2003","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.rbmo.2009.09.021_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1472-6483(10)60339-2","article-title":"A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS","volume":"15","author":"Aboulghar","year":"2007","journal-title":"Reproductive BioMedicine Online"},{"key":"10.1016\/j.rbmo.2009.09.021_bib3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/humrep\/deg116","article-title":"Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome. An aggressive, but perhaps life-saving procedure","volume":"18","author":"Amarin","year":"2003","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2009.09.021_bib4","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/oxfordjournals.humrep.a138185","article-title":"The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome","volume":"8","author":"Asch","year":"1993","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2009.09.021_bib5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.fertnstert.2006.01.046","article-title":"Gonadotropin-releasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell cultures","volume":"86","author":"Asimakopoulos","year":"2006","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2009.09.021_bib6","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/humrep\/17.11.2787","article-title":"Embryo freezing for preventing ovarian hyperstimulation syndrome: a Cochrane review","volume":"17","author":"D\u2019Angelo","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2009.09.021_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review","volume":"8","author":"Delvigne","year":"2002","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.rbmo.2009.09.021_bib8","first-page":"211","article-title":"Systematic review of data concerning etiopathology of ovarian hyperstimulation syndrome","volume":"47","author":"Delvigne","year":"2002","journal-title":"International Journal of Fertility and Women\u2019s Medicine"},{"key":"10.1016\/j.rbmo.2009.09.021_bib9","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.fertnstert.2008.02.092","article-title":"Drugs in infertility and fetal safety","volume":"89","author":"Elizur","year":"2008","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2009.09.021_bib10","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1093\/humrep\/17.10.2548","article-title":"Continuation of GnRH agonist administration for 1 week, after HCG injection, prevents ovarian hyperstimulation syndrome following elective cryopreservation of all pronucleate embryos","volume":"17","author":"Endo","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2009.09.021_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1472-6483(10)60212-X","article-title":"Luteal phase oestradiol suppression by letrozole: a pilot study in oocyte donors","volume":"17","author":"Fatemi","year":"2008","journal-title":"Reproductive BioMedicine Online"},{"key":"10.1016\/j.rbmo.2009.09.021_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00414-006-0104-z","article-title":"An immunohistochemical study in a fatality due to ovarian hyperstimulation syndrome","volume":"120","author":"Fineschi","year":"2006","journal-title":"International Journal of Legal Medicine"},{"key":"10.1016\/j.rbmo.2009.09.021_bib13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.fertnstert.2008.04.042","article-title":"Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized, placebo-controlled trial","volume":"92","author":"Garcia-Velasco","year":"2009","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2009.09.021_bib14","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/humrep\/dem006","article-title":"Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study","volume":"22","author":"Griesinger","year":"2007","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2009.09.021_bib15","unstructured":"Hughes JN 2002 Ovarian stimulation for assisted reproduction technologies. In: Vayena E, Rowe PJ, Griffin PD, editors Current Practices and Controversies in Assisted Reproduction. Geneva: World Health Organization; 2002. p. 102\u2013125."},{"key":"10.1016\/j.rbmo.2009.09.021_bib16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0015-0282(16)53051-9","article-title":"Effect of treatment with gonadotropin-releasing hormone analogues on pregnancy outcome in the baboon","volume":"52","author":"Kang","year":"1989","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2009.09.021_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2003.05.032","article-title":"Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome","volume":"81","author":"Kol","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2009.09.021_bib18","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.fertnstert.2006.12.058","volume":"88","author":"Kolibianakis","year":"2007","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2009.09.021_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1472-6483(10)60419-1","article-title":"Management of severe OHSS using GnRH antagonist and blastocyst cryopreservation in PCOS patients treated with long protocol","volume":"18","author":"Lainas","year":"2009","journal-title":"Reproductive BioMedicine Online"},{"key":"10.1016\/j.rbmo.2009.09.021_bib20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1472-6483(10)60366-5","article-title":"Management of severe early ovarian hyperstimulation syndrome by re-initiation of GnRH antagonist","volume":"15","author":"Lainas","year":"2007","journal-title":"Reproductive BioMedicine Online"},{"key":"10.1016\/j.rbmo.2009.09.021_bib21","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1093\/humrep\/dei106","article-title":"In a flexible antagonist protocol, earlier, criteria-based initiation of GnRH antagonist is associated with increased pregnancy rates in IVF","volume":"20","author":"Lainas","year":"2005","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2009.09.021_bib22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0015-0282(02)03290-9","article-title":"Administration of methylprednisolone to prevent severe ovarian hyperstimulation syndrome in patients undergoing in vitro fertilization","volume":"78","author":"Lainas","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2009.09.021_bib23","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1210\/jcem-62-6-1250","article-title":"The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe","volume":"62","author":"Mais","year":"1986","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.rbmo.2009.09.021_bib24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/jc.80.2.430","article-title":"Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells","volume":"80","author":"Minaretzis","year":"1995","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.rbmo.2009.09.021_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","article-title":"Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment","volume":"58","author":"Navot","year":"1992","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2009.09.021_bib26","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0140-6736(84)92840-X","article-title":"Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins","volume":"2","author":"Porter","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.rbmo.2009.09.021_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.fertnstert.2004.05.005","article-title":"Ovarian hyperstimulation syndrome","volume":"82","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2009.09.021_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/humupd\/3.3.255","article-title":"The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome","volume":"3","author":"Rizk","year":"1997","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.rbmo.2009.09.021_bib29","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1093\/oxfordjournals.humrep.a135867","article-title":"\u2018Prolonged coasting\u2019: an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization","volume":"10","author":"Sher","year":"1995","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2009.09.021_bib30","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0015-0282(16)47726-5","article-title":"Effects of a gonadotropin-releasing hormone antagonist on hormonal levels in the pregnant baboon and on fetal outcome","volume":"41","author":"Siler-Khodr","year":"1984","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2009.09.021_bib31","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S1472-6483(10)61435-6","article-title":"Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles","volume":"13","author":"Tavaniotou","year":"2006","journal-title":"Reproductive BioMedicine Online"},{"key":"10.1016\/j.rbmo.2009.09.021_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.1.05685","article-title":"Effects of GnRH antagonist treatment on follicular development and angiogenesis in the primate ovary","volume":"183","author":"Taylor","year":"2004","journal-title":"Journal of Endocrinology"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648309000856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648309000856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T23:33:33Z","timestamp":1558654413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648309000856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1472648309000856"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2009.09.021","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}